Showing results (371-380 of 9,884) with videos related to
Sort By:
Pageof 989
Antibiotics (Basel, Switzerland)|January 21, 2023
Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious DiseasesBálint Rácz, Gabriella SpenglerAntibiotics (Basel, Switzerland)|January 21, 2023
The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic ChoicesNatalia G Vallianou, Alexandros Skourtis, Dimitris Kounatidis, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
Microbial Resistance to Antibiotics and Biofilm Formation of Bacterial Isolates from Different Carp Species and Risk Assessment for Public HealthNikola Puvača, Dragana Ljubojević Pelić, Miloš Pelić, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
Characteristics of tet(X4)-Producing Escherichia coli in Chicken and Pig Farms in Hunan Province, ChinaJie Yang, Gang Xiao, Ning Xiao, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
Determinants of Knowledge, Attitude, and Practices of Veterinary Drug Dispensers toward Antimicrobial Use and Resistance in Main Cities of Malawi: A Concern on Antibiotic StewardshipHenson Kainga, Marvin Collen Phonera, Ibrahim Chikowe, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional StudyMuhammad Muqaddas Mustafai, Mavra Hafeez, Safa Munawar, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in AdultsRaquel Carbonell, Gerard Moreno, Ignacio Martín-Loeches, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
Antibacterial Effect of 16 Essential Oils and Modulation of mex Efflux Pumps Gene Expression on Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates: Is Cinnamon a Good Fighter?Răzvan Lucian Coșeriu, Camelia Vintilă, Mirela Pribac, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in ZambiaNgula Monde, Musso Munyeme, Gershom Chongwe, et al.Antibiotics (Basel, Switzerland)|January 21, 2023
Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UKDelveen R Ibrahim, Christine E R Dodd, Dov J Stekel, et al.Pageof 989